Last summer, McMaster University biochemistry and biomedical sciences researchers happened to be working on new technology to isolate respiratory viruses in patients.
Canadian researchers are developing a "lab-in-a-box" that could make it cheaper and faster to diagnose cases of the novel coronavirus, particularly in remote areas of the world.
As the role of clinical laboratories grows more prominent in the diagnosis and treatment of patients with infectious diseases, there is mounting pressure on both the labs and the diagnostic tests they select.
As the coronavirus spreads more widely around the globe, scientists are starting to use a powerful new tool: a blood test that identifies people who have previously been exposed to the virus.
Please note: The virtual event that was scheduled for March 11th has been rescheduled for Wednesday March 18th, 2020 from 12pm-1pm (EST)
Click the link above for further details or to register if you can now attend!
Biomass fuels derived from various grasses could significantly mitigate global warming by reducing carbon, according to a long-term field study by researchers at Ben-Gurion University of the Negev (BGU) and Michigan State University (MSU).
Researchers have found that combining MRI-targeted biopsy and 12 core systematic biopsy for men with MRI-visible prostate lesions could help prevent misclassifications of prostate cancer.
Support for artificial intelligence (AI) and machine learning (ML) in healthcare has been mixed among anatomic pathologists and clinical laboratory leaders. Nevertheless, there’s increasing evidence that diagnostic systems based on AI and ML can be as accurate or more accurate at detecting disease than systems without them.
We need your help to grow this newsletter! Please pass along the subscription link to any colleague you think would benefit from hearing about med lab news.